We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




A Simpler Way to Cure Atrial Fibrillation

By HospiMedica staff writers
Posted on 05 Mar 2007
A new study reports the results of an effective new option for treating atrial fibrillation (AF), a common irregular heart rhythm that can cause stroke. More...


Cardiac surgeons at Washington University School of Medicine (St. Louis, MO, USA) have reported further results of the Cox-maze IV clinical study, a simplified cardiac ablation procedure the surgeons believe can replace the older cut and sew Cox-maze III, in which 10 precisely placed incisions in the heart muscle created a maze to redirect errant electrical impulses.

Cox-maze IV is performed with a clamp-like instrument that ablates heart tissue by using radiofrequency energy. By holding areas of the heart within the jaws of the device, surgeons can create lines of ablation, or scar tissue, on the heart muscle. The ablation lines redirect the abnormal electrical currents responsible for atrial fibrillation. In the older Cox-maze III procedure, the lines of ablation were made by cutting the heart muscle, sewing the incisions back together, and letting a scar form. The researchers found that Cox-maze IV was just as effective as Cox-maze III, yet takes one-third the time to perform. The findings were reported in the February 2007 issue of the Journal of Thoracic and Cardiovascular Surgery.

"This is the first documentation of the effectiveness of the ablation devices compared to the incisions of the Cox-maze III,” said Prof. Ralph Damiano Jr., M.D., chief of cardiac surgery at the School of Medicine, and a cardiac surgeon at Barnes-Jewish Hospital (St. Louis, MO, USA). "Instead of reserving the Cox-maze procedure for a select group of patients, we would urge use of this device for virtually all patients who have atrial fibrillation and are scheduled for other cardiac surgery.”

AF can cause fatigue, shortness of breath, exercise intolerance, and palpitations. Patients with the disorder are five times more likely to suffer from stroke and have up to a two-fold higher risk of death. For some patients, medications can control the abnormal heart rhythms and the risk of clotting associated with AF, but unlike the Cox-maze procedure, the drugs do not cure the disorder.


Related Links:
Washington University School of Medicine

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.